期刊文献+

不同剂量的糖皮质激素对复杂区域疼痛综合征1型大鼠骨折模型的治疗作用 被引量:1

Different-dosed glucocorticoid in treatment of tibial fracture rat model of complex regional pain syndrome type 1
下载PDF
导出
摘要 目的探讨不同剂量的激素治疗复杂区域疼痛综合征1(complex regional pain syndrome type 1,CRPS1)大鼠的疗效及其对肿瘤坏死因子-α(TNF-α)、血清P物质(SP)、巨噬细胞游走抑制因子(microphage migration inhibitory factor,MIF)表达的影响。方法 30只成年雄性SD大鼠,随机数字表法分3组,每组10只:治疗1、2组、对照组在进行骨折制动造模结束后分别以甲强龙4、20 mg/(kg.d)和生理盐水对应治疗,腹腔注射,连续1周。治疗前后检测动物疼痛行为,治疗结束后8 h、1、3周检测血清SP、MIF及TNF-α水平。结果两治疗组在不同剂量激素治疗后,肢体肿胀、疼痛不同程度缓解。治疗2组血清SP、MIF、TNF-α均明显低于对照组(P<0.01,P<0.05),在各个观察点疼痛阈值均高于治疗1组及对照组(P<0.05)。结论大剂量的糖皮质激素对大鼠骨折CRPS1模型疗效优于小剂量,且对炎症因子有显著且持续抑制作用,小剂量糖皮质激素可部分缓解肢体肿胀及疼痛,对部分细胞因子表达有即时抑制作用。不同剂量激素在CRPS1型的疗效差异与其能否抑制MIF有关。 Objective To determine the efficacy and possible mechanism of glucocorticoid at different doses in complex regional pain syndrome type 1(CRPS1) rat model and its effect on serum P substance(SP),macrophage migration inhibitory factor(MIF) and tumor necrosis factor alpha(TNF-α).Methods Thirty adult health SD rats were randomly divided into control group,treatment-1 group and treatment-2 group with 10 rats in each group.Methylprednisolone(MP) was abdominally administered in treatment-1 group [4 mg/(kg·d)] and treatment-2 group [20 mg/(kg·d)].Pain behaviors were observed after 1-week-treatment.Serum SP,MIF and TNF-α were measured by ELISA at 8 h,1 and 3 weeks after 1-week-treatment.Results Hindpaw edema and pain was better after 1-week-treatment in 2 groups.T-2 group had higher pain threshold and lower serum levels of SP,MIF and TNF-α when compared to T-1 group and control group(P0.01,0.05).Conclusion It is suggested high-dose glucocorticoid is more effective in releasing edema and pain in CRPS1 rat model than low-dose glucocorticoid.Glucocorticoid might be through instantly suppressing some inflammatory factors.The difference of different doses of glucocorticoid might be due to whether suppresses MIF.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第5期423-426,共4页 Journal of Third Military Medical University
关键词 复杂区域性疼痛综合征1型 P物质 糖皮质激素 巨噬细胞游走抑制因子 肿瘤坏死因子 complex regional pain syndrome glucocorticoid substance P macrophage migration inhibitory factor tumor necrosis factor
  • 相关文献

参考文献13

  • 1Kalita J,Vajpayee A,Misra U K.Comparison of prednisolone with pi-roxicam in complex regional pain syndrome following stroke:a random-ized controlled trial[J].QJM,2006,99(2):89-95.
  • 2Christensen K,Jensen E M,Noer I.The reflex dystrophy syndrome re-sponse to treatment with systemic corticosteroids[J].Acta Chir Scand,1982,148(8):653-655.
  • 3Stanton-Hicks M D,Burton A W,Bruehl S P,et al.An updated inter-disciplinary clinical pathway for CRPS:report of an expert panel[J].Pain Pract,2002,2(1):1-16.
  • 4Wei T,Li W W,Guo T Z,et al.Post-junctional facilitation of Sub-stance P signaling in a tibia fracture rat model of complex regional pain syndrome type I[J].Pain,2009,144(3):278-286.
  • 5Chaplan S R,Bach F W,Pogrel J W,et al.Quantitative assessment of tactile allodynia in the rat paw[J].J Neurosci Methods,1994,53(1):55-63.
  • 6Sarangi P P,Ward A J,Smith E J,et al.Algodystrophy and osteopo-rosis after tibial fractures[J].J Bone Joint Surg Br,1993,75(3):450-452.
  • 7Geurts A C,Visschers B A,Van-Limbeek J,et al.Systematic review of aetiology and treatment of post-stroke hand oedema and shoulder-hand syndrome[J].Scand J Rehabil Med,2000,32(1):4-10.
  • 8Uceyler N,Eberle T,Rolke R,et al.Differential expression patterns of cytokines in complex regional pain syndrome[J].Pain,2007,132(1/2):195-205.
  • 9Bruehl S.An update on the pathophysiology of complex regional pain syndrome[J].Anesthesiology,2010,113(3):713-725.
  • 10Calandra T,Roger T.Macrophage migration inhibitory factor:a regulator of innate immunity[J].Nat Rev Immunol,2003,3(10):791-800.

同被引文献23

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部